Download PDFPDF
Original article
Phenotypical difference in deamination of cytarabine is not evident in induction therapy for acute myeloid leukaemia
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address